Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease

Identifieur interne : 001025 ( Main/Exploration ); précédent : 001024; suivant : 001026

Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease

Auteurs : Esther Cubo [Espagne] ; Miguel Gonzalez [Espagne] ; Inés Del Puerto [Espagne] ; Justo Garcia De Yebenes [Espagne] ; Olga Fernández Arconada [Espagne] ; José Maria Trejo Gabriel Y Galan [Espagne]

Source :

RBID : Pascal:12-0198679

Descripteurs français

English descriptors

Abstract

Background: Classically, clinical trials are based on the placebo-control design. Our aim was to analyze the placebo effect in Huntington's disease. Methods: Placebo data were obtained from an international, longitudinal, placebo-controlled trial for Huntington's disease (European Huntington's Disease Initiative Study Group). One-hundred and eighty patients were evaluated using the Unified Huntington Disease Rating Scale over 36 months. A placebo effect was defined as an improvement of at least 50% over baseline scores in the Unified Huntington Disease Rating Scale, and clinically relevant when at least 10% of the population met it. Results: Only behavior showed a significant placebo effect, and the proportion of the patients with placebo effect ranged from 16% (first visit) to 41 % (last visit). Nondepressed patients with better functional status were most likely to be placebo-responders over time. Conclusions: In Huntington's disease, behavior seems to be more vulnerable to placebo than overall motor function, cognition, and function.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease</title>
<author>
<name sortKey="Cubo, Esther" sort="Cubo, Esther" uniqKey="Cubo E" first="Esther" last="Cubo">Esther Cubo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gonzalez, Miguel" sort="Gonzalez, Miguel" uniqKey="Gonzalez M" first="Miguel" last="Gonzalez">Miguel Gonzalez</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Mathematics, University of Extremadura</s1>
<s2>Badajoz</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Badajoz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Del Puerto, Ines" sort="Del Puerto, Ines" uniqKey="Del Puerto I" first="Inés" last="Del Puerto">Inés Del Puerto</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Mathematics, University of Extremadura</s1>
<s2>Badajoz</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Badajoz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Yebenes, Justo Garcia" sort="De Yebenes, Justo Garcia" uniqKey="De Yebenes J" first="Justo Garcia" last="De Yebenes">Justo Garcia De Yebenes</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Tissue Bank for Neurological Research, Ramon y Cajal, University Hospital</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Arconada, Olga Fernandez" sort="Arconada, Olga Fernandez" uniqKey="Arconada O" first="Olga Fernández" last="Arconada">Olga Fernández Arconada</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Trejo Gabriel Y Galan, Jose Maria" sort="Trejo Gabriel Y Galan, Jose Maria" uniqKey="Trejo Gabriel Y Galan J" first="José Maria" last="Trejo Gabriel Y Galan">José Maria Trejo Gabriel Y Galan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">12-0198679</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0198679 INIST</idno>
<idno type="RBID">Pascal:12-0198679</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000220</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002A94</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000098</idno>
<idno type="wicri:doubleKey">0885-3185:2012:Cubo E:placebo:effect:characteristics</idno>
<idno type="wicri:Area/Main/Merge">001077</idno>
<idno type="wicri:Area/Main/Curation">001025</idno>
<idno type="wicri:Area/Main/Exploration">001025</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease</title>
<author>
<name sortKey="Cubo, Esther" sort="Cubo, Esther" uniqKey="Cubo E" first="Esther" last="Cubo">Esther Cubo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gonzalez, Miguel" sort="Gonzalez, Miguel" uniqKey="Gonzalez M" first="Miguel" last="Gonzalez">Miguel Gonzalez</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Mathematics, University of Extremadura</s1>
<s2>Badajoz</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Badajoz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Del Puerto, Ines" sort="Del Puerto, Ines" uniqKey="Del Puerto I" first="Inés" last="Del Puerto">Inés Del Puerto</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Mathematics, University of Extremadura</s1>
<s2>Badajoz</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Badajoz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Yebenes, Justo Garcia" sort="De Yebenes, Justo Garcia" uniqKey="De Yebenes J" first="Justo Garcia" last="De Yebenes">Justo Garcia De Yebenes</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Tissue Bank for Neurological Research, Ramon y Cajal, University Hospital</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Arconada, Olga Fernandez" sort="Arconada, Olga Fernandez" uniqKey="Arconada O" first="Olga Fernández" last="Arconada">Olga Fernández Arconada</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Trejo Gabriel Y Galan, Jose Maria" sort="Trejo Gabriel Y Galan, Jose Maria" uniqKey="Trejo Gabriel Y Galan J" first="José Maria" last="Trejo Gabriel Y Galan">José Maria Trejo Gabriel Y Galan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Clinical trial</term>
<term>Huntington disease</term>
<term>Nervous system diseases</term>
<term>Placebo</term>
<term>Placebo effect</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Chorée de Huntington</term>
<term>Pathologie du système nerveux</term>
<term>Effet placebo</term>
<term>Essai clinique</term>
<term>Placebo</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: Classically, clinical trials are based on the placebo-control design. Our aim was to analyze the placebo effect in Huntington's disease. Methods: Placebo data were obtained from an international, longitudinal, placebo-controlled trial for Huntington's disease (European Huntington's Disease Initiative Study Group). One-hundred and eighty patients were evaluated using the Unified Huntington Disease Rating Scale over 36 months. A placebo effect was defined as an improvement of at least 50% over baseline scores in the Unified Huntington Disease Rating Scale, and clinically relevant when at least 10% of the population met it. Results: Only behavior showed a significant placebo effect, and the proportion of the patients with placebo effect ranged from 16% (first visit) to 41 % (last visit). Nondepressed patients with better functional status were most likely to be placebo-responders over time. Conclusions: In Huntington's disease, behavior seems to be more vulnerable to placebo than overall motor function, cognition, and function.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Espagne</li>
</country>
<region>
<li>Communauté de Madrid</li>
</region>
<settlement>
<li>Madrid</li>
</settlement>
</list>
<tree>
<country name="Espagne">
<noRegion>
<name sortKey="Cubo, Esther" sort="Cubo, Esther" uniqKey="Cubo E" first="Esther" last="Cubo">Esther Cubo</name>
</noRegion>
<name sortKey="Arconada, Olga Fernandez" sort="Arconada, Olga Fernandez" uniqKey="Arconada O" first="Olga Fernández" last="Arconada">Olga Fernández Arconada</name>
<name sortKey="De Yebenes, Justo Garcia" sort="De Yebenes, Justo Garcia" uniqKey="De Yebenes J" first="Justo Garcia" last="De Yebenes">Justo Garcia De Yebenes</name>
<name sortKey="Del Puerto, Ines" sort="Del Puerto, Ines" uniqKey="Del Puerto I" first="Inés" last="Del Puerto">Inés Del Puerto</name>
<name sortKey="Gonzalez, Miguel" sort="Gonzalez, Miguel" uniqKey="Gonzalez M" first="Miguel" last="Gonzalez">Miguel Gonzalez</name>
<name sortKey="Trejo Gabriel Y Galan, Jose Maria" sort="Trejo Gabriel Y Galan, Jose Maria" uniqKey="Trejo Gabriel Y Galan J" first="José Maria" last="Trejo Gabriel Y Galan">José Maria Trejo Gabriel Y Galan</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001025 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001025 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:12-0198679
   |texte=   Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024